2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

Data Compilation
#PharmaFlow

Pipeline Prospector Aug 2024: Otsuka buys Jnana, Lilly’s market cap gains by over US$ 108 bn post new guidance

Stock Recap
#PipelineProspector

N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)]--D-gluconic acid (1/2)

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

47 API Suppliers, 28 USDMF, 9 CEP/COS, 9 JDMF, 7 EU WC, 1 VMF, 15 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

165 FDF Dossiers, 49 FDA Orange Book, 17 Europe, 67 Canada, 9 South Africa, 23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, METERED;TOPICAL - 4%, SOLUTION;TOPICAL - 2%, TABLET;DENTAL - 2.5MG, SOLUTION;TOPICAL - 2%;70%, SPONGE;TOPICAL - 2%;70% (1.5ML), SPONGE;TOPICAL - 2%;70% (10.5ML), SPONGE;TOPICAL - 2%;70% (1ML), SPONGE;TOPICAL - 2%;70% (26ML), SPONGE;TOPICAL - 2%;70% (3ML), SOLUTION;TOPICAL - 61%;1%, SWAB;TOPICAL - 3.15%;70% (1.6ML), SWAB;TOPICAL - 3.15%;70% (1ML), SWAB;TOPICAL - 3.15%;70% (5.1ML), SWAB;TOPICAL - 2%;70% (0.67ML), SWAB;TOPICAL - 2%;70% (1.75ML), SWAB;TOPICAL - 2%;70% (5.25ML)

RELATED EXCIPIENT COMPANIES

5 Rochem International Inc, 4 SPI Pharma, 2 Seqens, 12 DKSH, 1 Jai Radhe Sales, 2 Nippon Fine Chemical, 1 Pharm-RX Chemical, 3 Boai NKY Pharmaceuticals Ltd, 1 Gangwal Healthcare, 12 Nanjing Well Pharmaceutical, 3 Pfanstiehl, 4 ACG Worldwide, 18 Actylis, 1 Alcedo Pharmachem, 23 BASF, 2 BioSpectra, 1 Clariant, 6 Corel Pharma Chem, 4 Finar, 5 Gangwal Chemicals, 2 Ideal Cures Pvt Ltd, 9 Kerry, 1 Kima Chemical, 3 Lonza Capsugel, 1 Lubrizol Life Science Health, 3 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pluviaendo, 1 Qualicaps, 19 Roquette, 16 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

51 Topical, 35 Solubilizers, 32 Parenteral, 31 Thickeners and Stabilizers, 23 Coating Systems & Additives, 19 Film Formers & Plasticizers, 19 Fillers, Diluents & Binders, 11 Surfactant & Foaming Agents, 11 Rheology Modifiers, 11 Controlled & Modified Release, 10 Taste Masking, 10 Emulsifying Agents, 10 Co-Processed Excipients, 8 Empty Capsules, 5 Direct Compression, 5 Chewable & Orodispersible Aids, 5 Lubricants & Glidants, 4 API Stability Enhancers, 4 Granulation, 2 Disintegrants & Superdisintegrants, 1 Soft Gelatin

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 22 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 4 Finished Drug Prices

MARKET PLACE

32 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

9 US Patents, 1 US Exclusivities

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	VMF No.	Subject	Received Date	Status	Type
	Cronus Pharma	U.S.A	CRONUS PHARMA SPECIALTIES INDIA PVT LTD	3754	Chlorhexidine Gluconate	1979-11-01	Active	II

List of Veterinary Master File (VMF) of N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)]--D-gluconic acid (1/2) Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic Diamide)]--D-gluconic Acid (1/2)

N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)]--D-gluconic acid (1/2)

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

47 API Suppliers

28 USDMF

9 CEP/COS

9 JDMF

7 EU WC

1 VMF

15 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

FINISHED DOSAGE FORMULATIONS

165 FDF Dossiers

49 FDA Orange Book

17 Europe

67 Canada

9 South Africa

23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, METERED;TOPICAL - 4%

SOLUTION;TOPICAL - 2%

TABLET;DENTAL - 2.5MG

SOLUTION;TOPICAL - 2%;70%

SPONGE;TOPICAL - 2%;70% (1.5ML)

SPONGE;TOPICAL - 2%;70% (10.5ML)

SPONGE;TOPICAL - 2%;70% (1ML)

SPONGE;TOPICAL - 2%;70% (26ML)

SPONGE;TOPICAL - 2%;70% (3ML)

SOLUTION;TOPICAL - 61%;1%

SWAB;TOPICAL - 3.15%;70% (1.6ML)

SWAB;TOPICAL - 3.15%;70% (1ML)

SWAB;TOPICAL - 3.15%;70% (5.1ML)

SWAB;TOPICAL - 2%;70% (0.67ML)

SWAB;TOPICAL - 2%;70% (1.75ML)

SWAB;TOPICAL - 2%;70% (5.25ML)

RELATED EXCIPIENT COMPANIES

5 Rochem International Inc

4 SPI Pharma

2 Seqens

12 DKSH

1 Jai Radhe Sales

2 Nippon Fine Chemical

1 Pharm-RX Chemical

3 Boai NKY Pharmaceuticals Ltd

1 Gangwal Healthcare

12 Nanjing Well Pharmaceutical

3 Pfanstiehl

4 ACG Worldwide

18 Actylis

1 Alcedo Pharmachem

23 BASF

2 BioSpectra

1 Clariant

6 Corel Pharma Chem

4 Finar

5 Gangwal Chemicals

2 Ideal Cures Pvt Ltd

9 Kerry

1 Kima Chemical

3 Lonza Capsugel

1 Lubrizol Life Science Health

3 Microlex e.U

1 Nanjing Bold Chemical

2 Nomisma Healthcare

1 Novo Excipients

2 Pluviaendo

1 Qualicaps